Search results
Scientists link oocyte-specific histone H1FOO to better iPS cell generation
Phys.org· 2 days agoA joint research team led by Dr. Akira Kunitomi, a former postdoctoral fellow at CiRA (currently a...
Designing a novel substrate for myogenic differentiation from induced pluripotent stem cells
Phys.org· 5 days agoSince their discovery, researchers have repeatedly demonstrated the potential medical applications of differentiated cells and tissues generated from induced pluripotent & ...
Breakthrough by Shanghai doctors uses stem cells to cure diabetes
China Daily· 3 days agoA paper about the medical breakthrough, achieved after more than a decade of endeavor by a team of doctors at the hospital, was published on the website of the journal Cell
Engineering mini human hearts to study pregnancy complications and birth defects
The Raw Story· 19 hours agoTo this day, the mechanisms of human heart development remain elusive. Researchers know the heart is...
Gameto Announces New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solution...
KOLR - KSFX Ozarks· 4 days ago"This study is the first to demonstrate the end-to-end process by which a therapy developed from induced pluripotent stem cells (iPSC) has the potential ...
Century Therapeutics Inc (IPSC) Q1 2024 Earnings: Aligns with EPS Projections Amid Strategic ...
GuruFocus.com via Yahoo Finance· 1 day agoThe company, renowned for its advanced cell therapy platform using induced pluripotent stem cells (iPSCs), reported a net loss of $28.06 ...
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical ...
GuruFocus.com via Yahoo Finance· 2 days agoCompany Overview Fate Therapeutics is at the forefront of developing next-generation treatments through its proprietary induced pluripotent stem
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoTheragent and Pluristyx Enter Partnership to Streamline and Advance iPSC-derived Therapy Development PR Newswire ARCADIA, Calif., May 7, 2024 ARCADIA, Calif., May 7, 2024 /PRNewswire/ -- Theragent Inc., a comprehensive CDMO focused on advancing
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy...
FOX 23 News Albany· 6 days agoGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced its participation in the 27th American Society of ...
Revolutionizing Alzheimer’s Research: Cornell Scientists Develop Groundbreaking Neuron Model
SciTechDaily· 5 days agoThe preclinical study, published April 5 in Cell, is a significant advancement in Alzheimer’s disease research. “Currently no therapies can stop the spread of tau aggregates ...
